共 142 条
- [1] Chiba K.(1995)Drug-drug interaction via metabolism by cytochrome P450 Farumashia 31 992-996
- [2] Monahan B. P.(1990)Torsades de pointes occurring in association with terfenadine use JAMA 264 2788-2790
- [3] Ferguson C. L.(1993)Mechanism of the cardiotoxic action of terfenadine JAMA 269 1532-1536
- [4] Killeavy E. S.(1997)Use of Clin. Pharmacokinet. 32 210-258
- [5] Lloyd B. K.(1996) and Arch. Dermatol. 132 1254-341
- [6] Troy J.(1998) data to estimate the likelihood of metabolic pharmacokinetic interactions Clin. Pharmacol. Ther. 63 332-110
- [7] Cantilena L. R.(1993)Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals [letter] Am. J. Med. 94 109-485
- [8] Woosley R. L.(1994)Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole Clin. Pharmacol. Ther. 55 481-607
- [9] Chen Y.(1994)Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome Clin. Pharmacol. Ther. 56 601-483
- [10] Freiman J. P.(1990)Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole Drug Metab. Dispos. 18 476-1199